Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis
T Yoshida, K Yamada, K Azuma, A Kawahara, H Abe… - Medical oncology, 2013 - Springer
… of adverse events (AEs) appears to differ between them at … a retrospective analysis of AEs
and drug efficacy in patients … received 250 mg gefitinib or 150 mg erlotinib once daily. The …
and drug efficacy in patients … received 250 mg gefitinib or 150 mg erlotinib once daily. The …
[HTML][HTML] A retrospective comparison of the clinical efficacy of gefitinib, erlotinib, and afatinib in Japanese patients with non-small cell lung cancer
A Fujiwara, M Yoshida, H Fujimoto, H Nakahara… - Oncology …, 2018 - ncbi.nlm.nih.gov
… less frequent and milder grade of adverse effects. However, comparable … retrospective
study showed comparable clinical efficacy of gefitinib, erlotinib, and afatinib in Japanese patients …
study showed comparable clinical efficacy of gefitinib, erlotinib, and afatinib in Japanese patients …
Comparison of effectiveness and adverse effects of gefitinib, erlotinib and icotinib among patients with non‑small cell lung cancer: A network meta‑analysis
Y Liu, Y Zhang, G Feng, Q Niu… - Experimental and …, 2017 - spandidos-publications.com
… , gefitinib, erlotinib and icotinib had similar effectiveness for the … study, a network meta-analysis
was performed to compare the effectiveness and adverse effects of gefitinib, erlotinib and …
was performed to compare the effectiveness and adverse effects of gefitinib, erlotinib and …
Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study
IF Emery, C Battelli, PL Auclair, K Carrier, DM Hayes - BMC cancer, 2009 - Springer
… way to increase the effectiveness of these agents is to rationally select patients based on …
data from our lung cancer patients to compare the benefits derived from erlotinib and gefitinib …
data from our lung cancer patients to compare the benefits derived from erlotinib and gefitinib …
A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients
P Thomas, B Vincent, C George… - Indian Journal of …, 2019 - journals.lww.com
… study was aimed to compare the effectiveness and safety of erlotinib and gefitinib in
NSCLC patients… The use of EGFR inhibitors can cause some adverse drug reactions (ADRs) …
NSCLC patients… The use of EGFR inhibitors can cause some adverse drug reactions (ADRs) …
[HTML][HTML] Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter study
WC Fan, CJ Yu, CM Tsai, MS Huang, CL Lai… - Journal of Thoracic …, 2011 - Elsevier
… study was to compare the efficacy of gefitinib and erlotinib in … were enrolled into this
retrospective study conducted at five … some differences in the frequency of adverse effects between …
retrospective study conducted at five … some differences in the frequency of adverse effects between …
Gefitinib and erlotinib in metastatic non-small cell lung cancer: a meta-analysis of toxicity and efficacy of randomized clinical trials
M Burotto, EE Manasanch, J Wilkerson, T Fojo - The oncologist, 2015 - academic.oup.com
… , retrospective analyses had identified these subgroups as those most likely to benefit from
gefitinib and erlotinib [… death as an adverse event compared with the controls, were greater for …
gefitinib and erlotinib [… death as an adverse event compared with the controls, were greater for …
Comparison of gefitinib, erlotinib and afatinib in non‐small cell lung cancer: a meta‐analysis
… might be administered at a lower-than-standard dose to reduce adverse events while
retaining its efficacy. In fact, retrospective studies have shown that patients who were treated with …
retaining its efficacy. In fact, retrospective studies have shown that patients who were treated with …
Gefitinib provides similar effectiveness and improved safety than erlotinib for advanced non-small cell lung cancer: A meta-analysis
W Zhang, Y Wei, D Yu, J Xu, J Peng - Medicine, 2018 - journals.lww.com
… analysis of studies to compare the antitumor effectiveness and adverse effects (AEs) of gefitinib
and erlotinib … dose of erlotinib down to 25 mg/day in a retrospective study and achieved a …
and erlotinib … dose of erlotinib down to 25 mg/day in a retrospective study and achieved a …
[HTML][HTML] Efficacy and safety of afatinib for EGFR-mutant non-small cell lung cancer, compared with gefitinib or erlotinib
Y Kim, SH Lee, JS Ahn, MJ Ahn, K Park… - Cancer Research and …, 2019 - ncbi.nlm.nih.gov
… adverse events for afatinib, gefitinib, and erlotinib were approximately 7%, 3%, and 2%,
respectively, in our study, … efficacy in another retrospective study [19]. It showed that there was no …
respectively, in our study, … efficacy in another retrospective study [19]. It showed that there was no …